70,000 RSV Antibodies Released To Physicians, Hospitals Amid Shortage

The Centers for Disease Control and Prevention announced Thursday (Nov. 16) that 77,000 doses of Beyfortus (nirsevimab-alip), an antibody in short supply that protects against RSV in infants, will be released and immediately sent to physicians and hospitals through the Vaccines for Children Program and commercial channels. The move comes as FDA, HHS and CDC urge doctors to prioritize infants at high risk of illness, and also urge more doctors to use the RSV maternal vaccine to help protect babies...